These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3313782)

  • 21. [Detection of primary aldosteronism using the captopril test].
    Pirich K; Vierhapper H; Graninger W; Nowotny P; Waldhäusl W
    Wien Klin Wochenschr; 1987 Sep; 99(17):608-11. PubMed ID: 3314169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of middle-aged and elderly hypertension patients under outpatient conditions].
    Maevskiĭ AA
    Vrach Delo; 1990 Mar; (3):62-4. PubMed ID: 2368366
    [No Abstract]   [Full Text] [Related]  

  • 23. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
    Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
    Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary aldosteronism -- screening, diagnosis and therapy.
    Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E
    Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
    Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
    J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypotensive effect of 6-months cardiac rehabilitation in elderly patients].
    Kałka D; Sobieszczańska M; Marciniak W; Chorebała A; Markuszewski L; Metner E; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):95-100. PubMed ID: 17598651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
    Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
    Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [24 hour arterial pressure monitoring vs occasional measurements in comparative assessment of hypotensive treatment efficacy].
    Mazur ES; Gnedov DA; Bogdanova EK
    Klin Med (Mosk); 1999; 77(7):50-2. PubMed ID: 10483168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectiveness of long-term treatment of patients with hypertension].
    Gurgenian SV; Mikaelian ES; Pogosian SA; Babaian AS; Arutiunian EA
    Ter Arkh; 1988; 60(2):89-92. PubMed ID: 2966992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The long-term drug therapy of patients with mild arterial hypertension (the results of a 5-year observation)].
    Almazov VA; Brodskaia IS; Shliakhto EV
    Ter Arkh; 1992; 64(9):94-7. PubMed ID: 1481167
    [No Abstract]   [Full Text] [Related]  

  • 34. [The efficacy of a program of arterial hypertension prevention among an organized population (the results of a 5-year observation)].
    El'garov AA; Inarokova AM
    Ter Arkh; 1992; 64(1):16-9. PubMed ID: 1387987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasmatic renin activity in essential arterial hypertension. Hyporeninemic hypertension].
    Gutiérrez Millet V; Casado Pérez S; Ruilope Urioste LM; Hernando Avendaño L
    Rev Clin Esp; 1975 Apr; 137(2):105-14. PubMed ID: 1144838
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of outpatient treatment of essential hypertension].
    Krupa-Wojciechowska B; Leonowicz K; Gockowski K
    Wiad Lek; 1975 Sep; 28(18):1541-6. PubMed ID: 1163041
    [No Abstract]   [Full Text] [Related]  

  • 37. Antihypertensive treatment and plasma renin activity in essential hypertension.
    Chen WY; Hsieh BS; Yen TS; Cheng JT; Yang SM
    Taiwan Yi Xue Hui Za Zhi; 1976 Dec; 75(12):665-73. PubMed ID: 1071754
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term experience of spironolactone in essential hypertension.
    Jeunemaitre X; Kreft-Jais C; Chatellier G; Julien J; Degoulet P; Plouin PF; Ménard J; Corvol P
    Kidney Int Suppl; 1988 Oct; 26():S14-7. PubMed ID: 3199684
    [No Abstract]   [Full Text] [Related]  

  • 39. [Essential hypertension with low and high renin levels. Comparison of the results of long-term therapy].
    Widimský J; Horký K; Gregorová I; Dvoráková J
    Cas Lek Cesk; 1987 May; 126(19):582-5. PubMed ID: 3297343
    [No Abstract]   [Full Text] [Related]  

  • 40. Renin profiling to predict response to antihypertensive therapy.
    Blaufox MD; Wassertheil-Smoller S
    JAMA; 1999 Mar; 281(9):793-4. PubMed ID: 10070992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.